Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Prevention of infections after bone marrow transplantation Age: Adult |
Dose: Intravenous – 500 mg/kg Frequency: weekly |
|
Indication: Increase platelet count Age: Adult Condition: idiopathic thrombocytopenic purpura |
Dose: Intravenous – 400 mg/kg Frequency: daily Duration: 2-5 consecutive days |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Primary immunodeficiency Age: 2 years and older |
Dose: Intravenous – 300 to 800 mg/kg Frequency: Every 3 to 4 weeks |
|
Indication: Chronic immune thrombocytopenic purpura Age: Child |
Dose: Intravenous – 1 g/kg Frequency: Daily Duration: 2 consecutive days |
Administration
- For IM use only
- Give slowly
Side Effect
- Dizziness
- light-headedness
- nausea
- vomiting
- allergic and cutaneous reactions
- Local pain and tenderness at the site of inj
- IV administration may lead to systemic effects such as headache
- chills and fever
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Live measles vaccine, live mumps vaccine, live rubella vaccine, live varicella vaccine
|
May interfere with the immune response; these vaccines should be given at least 3 wk before or 3 mth after the admin of the immunoglobulins
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Selective IgA deficiency
|
Risk of severe allergic reaction
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Details coming soon
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.